Studying the role of macrophages in circulating prostate cancer cells by in vivo flow cytometry

Journal of Innovative Optical Health Sciences

Volumn 5, Issue 4, 2012, Pages

  Guo, Jin ^a   Fan, Zhichao ^a   Gu, Zhengqin ^b   Wei, Xunbin ^a,b  

^a FUDAN UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Circulating tumor cells; In vivo flow cytometer; Liposome encapsulated clodronate; Macrophages; Prostate cancer

Indexed keywords

CANCER METASTASIS; CANCER MODELS; CIRCULATING TUMOR CELLS; CONTROL GROUPS; DEPLETION KINETICS; FLOW-CYTOMETER; IMAGING DATA; IN-VIVO; LIPOSOME-ENCAPSULATED CLODRONATE; MALIGNANT CELLS; MULTI-STEP; PHAGOCYTOSE; PROSTATE CANCER CELLS; PROSTATE CANCERS; SMALL ANIMAL; SURVIVAL RATE; TUMOR METASTASIS; TUMOR PROGRESSIONS;

ANTIGEN-ANTIBODY REACTIONS; DISEASES; FLOW CYTOMETRY; KINETICS; MAMMALS; PATHOLOGY; TUMORS;

MACROPHAGES;

EID: 84870929001     PISSN: 17935458     EISSN: 17937205     Source Type: Journal    
DOI: 10.1142/S1793545812500277     Document Type: Article

References (34)

1. E. Ruoslahti, "How cancer spreads," Sci. Amer. 275, 72 - 77 (1996).
2. L. Weiss, "Metastatic inefficiency," Adv. Cancer Res. 54, 159 - 211 (1990).
3. C. W. Wong, A. Lee, L. Shientag, J. Yu, Y. Dong, G. Kao, A. B. Al-Mehdi, E. J. Bernhard, R. J. Muschel, "Apoptosis: An early event in metastatic inefficiency," Cancer Res. 61, 333 - 338 (2001).
4. J. E. Damber, G. Aus, "Prostate cancer," Lancet 371, 1710 - 1721 (2008).
5. A. W. Hsing, A. P. Chokkalingam, "Prostate cancer epidemiology," Front. Biosci. 11, 1388 - 1413 (2006).
6. A. Sica, V. Bronte, "Altered macrophage differentiation and immune dysfunction in tumor development," J. Clin. Invest. 117, 1155 - 1166 (2007).
7. S. J. Oosterling, G. J. V. D. Bij, G. A. Meijer, C. W. Tuk, E. V. Rooijen, N. V. Rooijen, S. Meijer, J. R. V. D. Sijp, R. H. Beelen, M. V. Egmond, "Macrophages direct tumour histology and clinical outcome in a colon cancer model," J. Pathol. 207, 147 - 155 (2005).
8. G. Heuff, H. S. Oldenburg, H. Boutkan, J. J. Visser, R. H. Beelen, N. V. Rooijen, C. D. Dijkstra, S. Meyer, "Enhanced tumour growth in the rat liver after selective elimination of Kupffer cells," Cancer Immunol. Immunother. 37, 125 - 130 (1993).
9. L. G. Bayon, M. A. Izquierdo, I. Sirovich, N. V. Rooijen, R. H. Beelen, S. Meijer, "Role of Kupffer cells in arresting circulating tumor cells and controlling metastatic growth in the liver," Hepatology 23, 1224 - 1231 (1996).
10. J. Condeelis, J. W. Pollard, "Macrophages: Obligate partners for tumor cell migration, invasion, and metastasis," Cell 124, 263 - 266 (2006).
11. J. Y. Shih, A. Yuan, J. J. W. Chen, P. C. Yang, "Tumor-associated macrophage: Its role in cancer invasion and metastasis," J. Cancer Molec. 2, 101 - 106 (2006).
12. E. Y. Lin, A. V. Nguyen, R. G. Russell, J. W. Pollard, "Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy," J. Exp. Med. 193, 727 - 740 (2001).
13. I. F. Lissbrant, P. Stattin, P. Wikstrom, J. E. Damber, L. Egevad, A. Bergh, "Tumor associated macrophages in human prostate cancer: Relation to clinicopathological variables and survival," Int. J. Oncol. 17, 445 - 451 (2000).
14. P. Seiler, P. Aichele, B. Odermatt, H. Hengartner, R. M. Zinkernagel, R. A. Schwendener, "Crucial role of marginal zone macrophages and marginal zone metallophils in the clearance of lymphocytic choriomeningitis virus infection," Eur. J. Immunol. 27, 2626 - 2633 (1997).
15. J. W. Tyner, O. Uchida, N. Kajiwara, E. Y. Kim, A. C. Patel, M. P. O'Sullivan, M. J. Walter, R. A. Schwendener, D. N. Cook, T. M. Danoff, M. J. Holtzman, "CCL5/CCR5 interaction provides anti-apoptotic signals for macrophage survival during viral infection," Nat. Med. 11, 1180 - 1187 (2005).
16. N. V. Rooijen, A. M. Sanders, T. K. V. D. Berg, "Apoptosis of macrophages induced by liposomemediated intracellular delivery of clodronate and propamidine," J. Immunol. Methods 193, 93 - 99 (1996).
17. N. V. Rooijen, A. Sanders, "Liposomes mediated depletion of macrophages: Mechanism of action, preparation of liposomes and applications," J. Immunol. Methods 174, 83 - 93 (1994).
18. N. V. Rooijen, J. Bakker, A. Sanders, "Transient suppression of macrophage functions by liposomeencapsulated drugs," Trends Biotechnol. 15, 178 - 185 (1997).
19. J. Novak, I. Georgakoudi, X. Wei, A. Prossin, C. P. Lin, "In vivo flow cytometer for realtime detection and quantification of circulating cells," Opt. Lett. 29, 77 - 79 (2004).
20. I. Georgakoudi, N. Solban, J. Novak, W. L. Rice, X. Wei, T. Hasan, C. P. Lin, "In vivo flow cytometry: A new method for enumerating circulating cancer cells," Cancer Res. 64, 5044 - 5047 (2004).
21. S. Boutrus, C. Greiner, D. Hwu, M. Chan, C. Kuperwasser, C. P. Lin, I. Georgakoudi, "Portable two-color in vivo flow cytometer for real-time detection of fluorescently-labelled circulating cells," J. Biomed. Opt. 12, 020507-1-020507-3 (2007).
22. D. A. Sipkins, X. Wei, J. W. Wu, J. M. Runnels, D. Cote, T. K. Means, A. D. Luster, D. T. Scadden, C. P. Lin, "In vivo imaging of specialized bone marrow endothelial microdomains for tumor engraftment," Nature 435, 969 - 973 (2005).
23. W. He, H. F. Wang, L. C. Hartmann, J. X. Cheng, P. S. Low, "In vivo quantitation of rare circulating tumor cells by multiphoton intravital flow cytometry," Proc. Natl. Acad. Sci. USA 104, 11, 760 - 11, 765 (2007).
24. Y. Li, J. Guo, C. Wang, Z. Fan, G. Liu, C. Wang, Z. Gu, D. Damm, A. Mosig, X. Wei, "Circulation times of prostate cancer and hepatocellular carcinoma cells by in vivo flow cytometry," Cytometry A 79, 848 - 854 (2011).
25. V. V. Tuchin, A. Tarnok, V. P. Zharov, "In vivo flow cytometry: A horizon of opportunities," Cytometry A 79, 737 - 745 (2011).
26. C. M. Pitsillides, J. M. Runnels, J. A. Spencer, L. Zhi, M. X. Wu, C. P. Lin, "Cell labeling approaches for fluorescence-based in vivo flow cytometry," Cytometry A 79, 758 - 765 (2011).
27. Z. C. Fan, Y. Jun, G. D. Liu, X. Y. Tan, X. F. Weng, W. Z. Wu, J. Zhou, X. B. Wei, "Real-time monitoring of rare circulating hepatocellular carcinoma cells in an orthotopic model by in vivo flow cytometry assesses resection on metastasis," Cancer Res. 72, 2683 - 2691 (2012).
28. M. Yin, S. Li, L. Yuan, H. Dai, "Separation, cultivation and identification of mouse peritoneal macrophages," Med. J. Wuhan University 27, 203 - 205 (2006).
29. K. H. V. D. Hoek, S. Maddocks, C. M. Woodhouse, N. V. Rooijen, S. A. Robertson, R. J. Norman, "Intrabursal injection of clodronate liposomes causes macrophage depletion and inhibits ovulation in the mouse ovary," Biol. Reprod. 62, 1059 - 1066 (2000).
30. N. V. Rooijen, N. Kors, G. Kraal, "Macrophage subset repopulation in the spleen: Differential kinetics after liposome-mediated elimination," J. Leukoc. Biol. 45, 97 - 104 (1989).
31. M. B. Jordan, N. V. Rooijen, S. Izui, J. Kappler, P. Marrack, "Liposomal clodronate as a novel agent for treating autoimmune hemolytic anemia in a mouse model," Blood 101, 594 - 601 (2003).
32. S. J. Huh, S. Liang, A. Sharma, C. Dong, G. P. Robertson, "Transiently entrapped circulating tumor cells interact with neutrophils to facilitate lung metastasis development," Cancer Res. 70, 6071 - 6082 (2010).
33. A. E. Koch, P. J. Polverini, S. L. Kunkel, L. A. Harlow, L. A. DiPietro, V. M. Elner, S. G. Elner, R. M. Strieter, "Interleukin-8 as a macrophage-derived mediator of angiogenesis," Science 258, 1798 - 1801 (1992).
34. J. J. Chen, P. L. Yao, A. Yuan, T. M. Hong, C. T. Shun, M. L. Kuo, Y. C. Lee, P. C. Yang, "Up-regulation of tumor interleukin-8 expression by infiltrating macrophages: Its correlation with tumor angiogenesis and patient survival in non-small cell lung cancer," Clin. Cancer Res. 9, 729 - 737 (2003).